SEARCH

SEARCH BY CITATION

References

  • [1]
    Kumar, P.S., Griffen, A.L., Barton, J.A., Paster, B.J., Moeschberger, M.L., Leys, E.J. (2003) New bacterial species associated with chronic periodontitis. J. Dent. Res. 82, 338344.
  • [2]
    Reid, G., Sanders, M.E., Gaskins, H.R., Gibson, G.R., Mercenier, A., Rastall, R.A., Roberfroid, M.B., Rowland, I., Cherbut, C., Klaenhammer, T.R. (2003) New scientific paradigms for probiotics and prebiotics. J. Clin. Gastroenterol. 37, 105118.
  • [3]
    Gibson, G.R., Roberfroid, M.B. (1995) Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. J. Nutr. 125, 14011412.
  • [4]
    Burton, J.P., Cadieux, P., Reid, G. (2003) Improved understanding of the bacterial vaginal microbiota of women before and after probiotic instillation. Appl. Environ. Microbiol. 69, 97101.
  • [5]
    Stebbings, S., Munro, K., Simon, M.A., Tannock, G., Highton, J., Harmsen, H., Welling, G., Seksik, P., Dore, J., Grame, G., Tilsala-Timisjarvi, A. (2002) Comparison of the faecal microflora of patients with ankylosing spondylitis and controls using molecular methods of analysis. Rheumatology 41, 13951401.
  • [6]
    Schell, M.A., Karmirantzou, M., Snel, B., Vilanova, D., Berger, B., Pessi, G., Zwahlen, M.C., Desiere, F., Bork, P., Delley, M., Pridmore, R.D., Arigoni, F. (2002) The genome sequence of Bifidobacterium longum reflects its adaptation to the human gastrointestinal tract. Proc. Natl. Acad. Sci. USA 99, 1442214427.
  • [7]
    Kleerebezem, M., Boekhorst, J., van Kranenburg, R., Molenaar, D., Kuipers, O.P., Leer, R., Tarchini, R., Peters, S.A., Sandbrink, H.M., Fiers, M.W.E.J., Stiekema, W., Klein Lankhorst, R.M., Bron, P.A., Hoffer, S.M., Nierop Groot, M.N., Kerkhoven, R., de Vries, M., Ursing, B., de Vos, W.M., Siezen, R.J. (2003) Complete genome sequence of Lactobacillus plantarum WCFS1. Proc. Natl. Acad. Sci. USA 100, 19901995.
  • [8]
    Pridmore, R.D., Berger, B., Desiere, F., Vilanova, D., Barretto, C., Pittet, A.C., Zwahlen, M.C., Rouvet, M., Altermann, E., Barrangou, R., Mollet, B., Mercenier, A., Klaenhammer, T., Arigoni, F., Schell, M.A. (2004) The genome sequence of the probiotic intestinal bacterium Lactobacillus johnsonii NCC 533. Proc. Natl. Acad. Sci. USA. 101, 25122517.
  • [9]
    Barrangou, R., Altermann, E., Hutkins, R., Cano, R., Klaenhammer, T. (2003) Functional and comparative genomic analyses of an operon involved in fructooligosaccharide utilization by Lactobacillus acidophilus. Proc. Nat. Acad. Sci. USA 100, 89578962.
  • [10]
    Ventura, M., Canchaya, C., Kleerebezem, M., de Vos, W.M., Siezen, R.J., Brussow, H. (2003) The prophage sequences of Lactobacillus plantarum WCFS1. Virology 316, 245255.
  • [11]
    Teuber, M., Meile, L., Schwarz, F. (1999) Acquired antibiotic resistance in lactic acid bacteria from food. Antonie van Leeuwenhoek 76, 115137.
  • [12]
    Ouwehand, A.C., Kirjavainen, P.V., Shortt, C., Salminen, S. (1999) Probiotics: mechanisms and established effects. Int. Dairy J. 9, 4352.
  • [13]
    Gill, H.S. (2003) Probiotics to enhance anti-infective defences in the gastrointestinal tract. Best Pract. Res. Clin. Gastroenterol. 17, 755773.
  • [14]
    Mack, D.R., Michail, S., Wei, S., McDougall, L., Hollingsworth, M.A. (1999) Probiotics inhibit enteropathogenic E. coli adherence in vitro by inducing mucin gene expression. Am. J. Physiol. 276, G941G950.
  • [15]
    Lee, Y.-K., Puong, K.-Y. (2002) Competition for adhesion between probiotics and human gastrointestinal pathogens in the presence of carbohydrate. Brit. J. Nutr. 88 (Suppl. 1), S101S108.
  • [16]
    Wold, A.E. (2001) Immune effects of probiotics. Scand. J. Nutr. 45, 7685.
  • [17]
    Malin, M., Suomalainen, H., Saxelin, M., Isolauri, E. (1996) Promotion of IgA immune response in patients with Crohn’ s disease by oral bacteriotherapy with Lactobacillus GG. Scand. J. Gastroenterol. 36, 971974.
  • [18]
    Neish, A.S., Gewirtz, A.T., Zeng, H., Young, A.N., Hobert, M.E., Karmali, V., Rao, A.S., Madara, J.L. (2000) Prokaryotic regulation of epithelial responses by inhibition of IkappaB-alpha ubiquitination. Science 289, 15601563.
  • [19]
    Kirjavainen, P.V., Salminen, S.J., Isolauri, E. (2003) Probiotic bacteria in the maintenance of atopic disease: underscoring the importance of viability. J. Pediatr. Gastroenterol. Nutr. 36, 223227.
  • [20]
    Wolf, B.W., Wheeler, K.B., Ataya, D.G., Garleb, K.A. (1998) Safety and tolerance of Lactobacillus reuteri supplementation to a population infected with the human immunodeficiency virus. Food Chem. Toxicol. 36, 10851094.
  • [21]
    Cebra, J.J. (1999) Influences of microbiota on intestinal immune system development. Am. J. Clin. Nutr. 69, 1046S1051S.
  • [22]
    Marteau, P., Pochart, P., Dore, J., Bera-Maillet, C., Bernalier, A., Corthier, G. (2001) Comparative study of the bacterial groups within the human cecal and fecal microbiota. Appl. Environ. Microbiol. 67, 49394942.
  • [23]
    Blaut, M., Collins, M.D., Welling, G.W., Dore, J., van Loo, J., de Vos, W. (2002) Molecular biological methods for studying the gut microbiota: the EU human gut flora project. Brit. J. Nutr. 87, S203S211.
  • [24]
    Tannock, G.W. (2002) Molecular methods for exploring the intestinal ecosystem. Brit. J. Nutr. 87, S199S201.
  • [25]
    Zoetendal, E.G., Collier, C.T., Koike, S., Mackie, R.I., Gaskins, H.R. (2004) Molecular ecological analysis of the gastrointestinal microbiota: a review. J. Nutr. 134, 465472.
  • [26]
    Andoh, A., Tsujikawa, T., Fujiyama, Y. (2003) Role of dietary fiber and short-chain fatty acids in the colon. Curr. Pharmaceut. Des. 9, 347358.
  • [27]
    Hold, G.L., Schwiertz, A., Aminov, R.I., Blaut, M., Flint, H.J. (2003) Oligonucleotide probes that detect quantitatively significant groups of butyrate-producing bacteria in human feces. Appl. Environ. Microbiol. 69, 43204324.
  • [28]
    Perrin, S., Warchol, M., Grill, J.P., Schneider, F. (2001) Fermentations of fructo-oligosaccharides and their components by Bifidobacterium infantis ATCC 15697 on batch culture in semi-synthetic medium. J. Appl. Microbiol. 90, 859865.
  • [29]
    Gopal, P.K., Sullivan, P.A., Smart, J.B. (2001) Utilisation of galacto-oligosaccharides as selective substrates for growth by lactic acid bacteria including Bifidobacterium lactis DR10 and Lactobacillus rhamnosus DR20. Int. Dairy J. 11, 1925.
  • [30]
    Kaplan, H., Hutkins, R.W. (2000) Fermentation of fructo-oligosaccharides by lactic acid bacteria and bifidobacteria. Appl. Env. Microbiol. 66, 26822684.
  • [31]
    Palframan, R., Gibson, G.R., Rastall, R.A. (2003) Development of a quantitative tool for the comparison of the prebiotic effect of dietary oligosaccharides. Lett. Appl. Microbiol. 37, 281284.
  • [32]
    Zopf, D., Roth, S. (1996) Oligosaccharide anti-infective agents. Lancet 347, 10171021.
  • [33]
    Hirano, S., Nagao, N. (1989) Effects of chitosan, pectic acid, lysozyme, chitinase on the growth of several phytopathogens. Agric. Biol. Chem. 53, 30653066.
  • [34]
    S. Sekiguchi, Y. Miura, H. Kaneko, S.-I. Nishimura, N. Nishi, M. Iwase, S Tokura, Molecular weight dependency of antimicrobial activity by chitosan oligomers, K. ishinari E. Doi, Food hydrocolloids: structures, properties, and functions 1994, Press, New York. 71-76.
  • [35]
    Rycroft, C.E., Jones, M.R., Gibson, G.R., Rastall, R.A. (2001) A comparative study of the fermentation properties of prebiotic oligosaccharides. J. Appl. Microbiol. 91, 878887.
  • [36]
    Palframan, R., Gibson, G.R., Rastall, R.A. (2003) Effect of pH and dose on the growth of gut bacteria on prebiotic carbohydrates in vitro. Anaerobe 8, 287292.
  • [37]
    Rastall, R.A., Maitin, V. (2002) Prebiotics and synbiotics: towards the next generation. Curr. Opin. Biotechnol. 13, 490498.
  • [38]
    Rabiu, B.A., Jay, A.J., Gibson, G.R., Rastall, R.A. (2001) Synthesis and fermentation properties of novel galacto-oligosaccharides by β-galactosidases from Bifidobacterium species. Appl. Env. Microbiol. 67, 25262530.
  • [39]
    Tzortzis, G., Goulas, A.K., Baillon, M.L.A., Gibson, G.R., Rastall, R.A. (2004) In vitro evaluation of the fermentation properties of galactooligosaccharides synthesized by α-galactosidase from Lactobacillus reuteri. Appl. Microbiol. Biotechnol. 64, 106111.
  • [40]
    Mori, H., Sato, Y., Taketomo, N., Kamiyama, T., Yoshiyama, Y., Meguro, S., Sato, H., Kaneko, T. (1997) Isolation and structural identification of bifidogenic growth stimulator produced by Propionibacterium freudenreichii. J. Dairy Sci. 80, 19591964.
  • [41]
    Mackie, R.I., Sghir, A., Gaskins, H.R. (1999) Developmental microbial ecology of the neonatal gastrointestinal tract. Am. J. Clin. Nutr. 69, 1035S1045S.
  • [42]
    Favier, C.F., Vaughan, E.E., de Vos, W.M., Akkermans, A.D. (2002) Molecular monitoring of succession of bacterial communities in human neonates. Appl. Environ. Microbiol. 68, 219226.
  • [43]
    Salminen, S., Gibson, G.R., McCartney, A.L., Isolauri, E. (2004) Influence of mode of delivery on gut microbiota composition in seven year old children. Gut 53, 13881389.
  • [44]
    Mountzouris, K.C., McCartney, A.L., Gibson, G.R. (2002) Intestinal microflora of human infants and current trends for its nutritional modulation. Br. J. Nutr. 87, 405420.
  • [45]
    Saxelin, M., Chuang, N.H., Chassey, B., Rautelin, H., Makela, P.H., Salminen, S., Gorbach, S.L. (1996) Lactobacilli and bacteremia in Southern Finland 1989–1992. Clin. Infect. Dis. 22, 564566.
  • [46]
    Isolauri, E. (1997) Intestinal involvement in atopic disease. J. Royal Soc. Med. 90, 1520.
  • [47]
    Hoyos, A.B. (1999) Reduced incidence of necrotizing enterocolitis associated with enteral administration of Lactobacillus acidophilus and Bifidobacterium infantis to neonates in an intensive care unit. Int. J. Infect. Dis. 3, 197202.
  • [48]
    Dunne, C. (2001) Adaptation of bacteria to the intestinal niche: probiotics and gut disorder. Inflamm. Bowel Dis. 7, 136145.
  • [49]
    Griffin, I.J., Davila, P.M., Abrams, S.A. (2002) Non-digestible oligosaccharides and calcium absorption in girls with adequate calcium intakes. Brit. J. Nutr. 87 (Suppl. 2), S187S191.
  • [50]
    Hebuterne, X. (2003) Gut changes attributed to ageing: effects on intestinal microflora. Curr. Opin. Clin. Nutr. Metab. Care 6, 4954.
  • [51]
    Kleessen, B., Sykura, B., Zunft, H.-J., Blaut, M. (1997) Effects of inulin and lactose on fecal microflora, microbial activity and bowel habit in elderly constipated persons. Am. J. Clin. Nutr. 65, 13971402.
  • [52]
    Likotrafiti, E., Manderson, K., Tuohy, K.M., Gibson, G.R., Rastall, R.A. (2004) Molecular identification and anti-pathogen potential of putative probiotic bacteria isolated from faecal samples taken from healthy independent elderly individuals. Microb. Ecol. Health Dis. 16, 105112.
  • [53]
    Mattila-Sandholm, T., Blaut, M., Daly, C., de Vuyst, L., Gibson, G.R., Goosens, H., Knorr, D., Lucas, J., Lahteenmaki, L., Mercenier, A., Saarela, M., Shanahan, F., de Vos, W.M. (2002) Food, GI-tract functionality and human health cluster: ProEUHealth. Microb. Ecol. Health Dis. 14, 6574.
  • [54]
    Gilberg, K., Laouri, M., Wade, S., Isonaka, S. (2003) Analysis of medication use patterns: apparent overuse of antibiotics and underuse of prescription drugs for asthma, depression, and CHF. J. Manag. Care. Pharm. 9, 232237.
  • [55]
    Saran, S., Gopalan, S., Krishna, T.P. (2002) Use of fermented foods to combat stunting and failure to thrive. Nutrition 18, 393396.
  • [56]
    Agarwal, K.N., Bhasin, S.K. (2002) Feasibility studies to control acute diarrhoea in children by feeding fermented milk preparations Actimel and Indian Dahi. Eur. J. Clin. Nutr. 56 (Suppl. 4), S56S59.
  • [57]
    Sewankambo, N., Gray, R.H., Wawer, M.J., Paxton, L., McNaim, D., Wabwire-Mangen, F., Serwadda, D., Li, C., Kiwanuka, N., Hillier, S.L., Rabe, L., Gaydos, C.A., Quinn, T.C., Konde-Lule, J. (1997) HIV_1 infection associated with abnormal vaginal flora morphology and bacterial vaginosis. Lancet 350, 546550.
  • [58]
    Wiesenfeld, H.C., Hillier, S.L., Krohn, M.A., Landers, D.V., Swet, R.L. (2003) Bacterial vaginosis is a strong predictor of Neisseria gonorroeae and Chlamydia trachomatis infection. Clin. Infect. Dis. 36, 663668.
  • [59]
    Reid, G., Beuerman, D., Heinemann, C., Bruce, A.W. (2001) Probiotic Lactobacillus dose required to restore and maintain a normal vaginal flora. FEMS Immunol. Med. Microbiol. 32, 3741.
  • [60]
    Cadieux, P., Burton, J., Kang, C.Y., Gardiner, G., Braunstein, I., Bruce, A.W., Reid, G. (2002) Lactobacillus strains and vaginal ecology. J. Am. Med. Assoc. 287, 19401941.
  • [61]
    Freitas, M., Tavan, E., Cayuela, C., Diop, L., Sapin, C., Trugnan, G. (2003) Host–pathogens cross-talk. Indigenous bacteria and probiotics also play the game. Biol. Cell. 95, 503506.
  • [62]
    Pathmakanthan, S., Meance, S., Edwards, C.A. (2000) Probiotics: a review of human studies to date and methodological approaches. Microb. Ecol. Health Dis. 12, 1030.
  • [63]
    Playne, M.J., Crittenden, R. (1996) Commercially available oligosaccharides. Bull. Int. Dairy Fed. 313, 1022.
  • [64]
    Rastall, R.A., Hotchkiss Jr., A.T. Potential for the development of prebiotic oligosaccharides from biomass, Eggleston, G., Cote, G., Eds. Oligosaccharides in food and agriculture ACS Symposium Series. 849, 2003, American Chemical Society, Washington, DC, 44–53.
  • [65]
    de Vuyst, L., Degeest, B. (1999) Heteropolysaccharides from lactic acid bacteria. FEMS Microbiol. Rev. 23, 157177.
  • [66]
    Palcic, M.M. (1999) Biocatalytic synthesis of oligosaccharides. Curr. Opin. Biotechnol. 10, 616624.
  • [67]
    Tuomola, E., Crittenden, R., Playne, M., Isolauri, E., Salminen, S. (2001) Quality assurance criteria for probiotic bacteria. Am. J. Clin. Nutr. 73, 393S398S.
  • [68]
    Siuta-Cruce, P., Goulet, J. (2001) Improving probiotic survival rates. Food Technol. 55, 3642.
  • [69]
    Feord, J. (2002) Lactic acid bacteria in a changing legislative environment. Antonie van Leeuwenhoek 82, 353360.
  • [70]
    Katan, M.B., de Roos, N.M. (2003) Public health: toward evidence-based health claims for functional foods. Science 299, 206207.